Nandrolone and Tamoxifen Interaction

Avoid
Mechanism-based 75% confidence

Nandrolone and Tamoxifen have a potentially harmful interaction with 75% confidence. Both Nandrolone and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Both compounds affect the gonads, so monitoring these systems is recommended.

Compound Profiles

Nandrolone

Anabolic-Androgenic Steroid | Joint & Collagen Support

Nandrolone binds to the androgen receptor (AR) with affinity comparable to testosterone, promoting nitrogen retention, protein synthesis, and satellite cell activation in skeletal muscle tissue. Its anabolic effects are mediated through AR-dependent gene transcription that upregulates muscle-specific proteins including myosin heavy chain and IGF-1.

Half-life: ~6-12 days (decanoate) Typical dose: 100-200 mg/week (therapeutic) anabolic, healing, sexual health
5 alpha reductaseandrogen receptorigf1progesterone receptor androgenicblood pressure raisingcarcinogenic riskcardiotoxic
View full profile

Tamoxifen

Selective Estrogen Receptor Modulator | PCT & Breast Cancer Treatment

Tamoxifen competitively binds to estrogen receptors (primarily ERalpha) and exerts tissue-selective effects depending on the local coactivator and corepressor environment. In breast tissue and the hypothalamus, tamoxifen acts as an estrogen antagonist, blocking estradiol-mediated signaling.

Half-life: ~5-7 days Typical dose: 20-40mg oral daily pct
cyp3a4estrogen receptor anticoagulantcarcinogenic riskhepatotoxicpct agent
View full profile

Combined Organ Load

Gonads
moderate
Heart
low
Blood Vessels
low
Liver
low
Pituitary
low

Shared Safety Flags

2x 2 compounds share the carcinogenic-risk safety flag (Nandrolone, Tamoxifen). Monitor accordingly.
2x 2 hepatotoxic compounds (Nandrolone, Tamoxifen). Liver damage risk significantly increased. Include liver support (TUDCA/NAC) and monitor ALT/AST.
2x 2 compounds share the teratogenic safety flag (Nandrolone, Tamoxifen). Monitor accordingly.

Frequently Asked Questions

Can I take Nandrolone with Tamoxifen?

Combining Nandrolone with Tamoxifen is not recommended. Both Nandrolone and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently.

Is Nandrolone and Tamoxifen safe together?

This combination carries significant risk. Both Nandrolone and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. Consult a healthcare professional before combining.

What are the interactions between Nandrolone and Tamoxifen?

Both Nandrolone and Tamoxifen carry hepatotoxic risk. Combining hepatotoxic compounds significantly increases liver damage potential. If unavoidable, include liver support (TUDCA/NAC) and monitor ALT/AST frequently. This assessment has 75% confidence and is inferred from pharmacological mechanism analysis.

How should I time Nandrolone and Tamoxifen?

Nandrolone has a half-life of ~6-12 days (decanoate) and Tamoxifen has a half-life of ~5-7 days. No specific timing requirements identified for this combination, but separating administration can help monitor individual effects.

Check this pair in the full Interaction Checker Full comparison: Nandrolone vs Tamoxifen

This interaction analysis is compiled from research literature and pharmacological mechanism data. This assessment is inferred from known mechanisms and may not reflect all real-world outcomes. Always consult a healthcare professional before combining compounds.